GEN Exclusives

More »

GEN News Highlights

More »
May 16, 2007

Protagen Joins International Collaboration

  • Protagen entered into an international collaboration to develop antibodies against liver proteins with the Centre for Applied Proteomics (ZAP), Schunde Kangdi Antibody Biotech, and the Beijing Proteome Research Centre (Beijing PRC).

    The involvement of Protagen in the collaboration will be to develop tailor-made protein biochips that can be used to analyze quantitative antibody-binding profiles as well as any off-target activities of antibody candidates. Protagen’s UNIchip® is a research tool that identifies the most specific antibody candidates at an early stage of development.

    ZAP will use the UNIchip® to assess around 200 mAbs, generated by Schunde Kangdi Antibody Biotech and Beijing PRC. The results will be used to identify those antibodies that are most promising for future development as research tools, therapeutics, or for use in diagnostic kits. The industrial partners are sharing the worldwide commercialization rights for the antibodies analyzed.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?